FSTL1 is an antagonist of ERK1/2 phosphorylation during ciliogenesis and preadipocyte differentiation Article Swipe
Leonardo Santos
,
Lucía Guggeri
,
Carlos Escande
,
José L. Badano
,
Victoria Prieto-Echagüe
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1101/2024.02.21.581425
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1101/2024.02.21.581425
FSTL1 is a secreted glycoprotein that is involved in several processes in health and disease, including development, cardiovascular disease, cancer, inflammation, and obesity. The signaling pathways used by FSTL1 to act on target tissues seem to activate different intracellular mediators specific to each tissue and several of the mechanisms of action remain to be determined at the molecular level, including intracellular mediators and receptors. We have previously unveiled a novel role for FSTL1 in ciliogenesis and provided evidence for an Fstl1/cilia axis in preadipocyte differentiation. This pathway is relevant to the pathogenesis of obesity and of a group of conditions called ciliopathies since they are caused by the dysfunction of the primary cilia. This work aimed to identify intracellular mediators of FSTL1 action on ciliogenesis and adipogenesis. We analyzed ERK phosphorylation levels as well as cilia length in the absence of FSTL1 and in the presence of the pERK inhibitor U0126. We also analyzed the differentiation and cilia dynamics of U0126-treated preadipocytes and tested the ERK-mediated signaling by BMP4 in the presence of added extracellular Fstl1. Here, we propose that MAP kinase ERK is a mediator of ciliogenesis downstream of FSTL1 and provide additional data that suggest that FSTL1 antagonizes BMP non-canonical signaling to modulate ciliogenesis and adipogenesis. In sum, our data reinforce the interest on the axis FSTL1/cilia in the modulation of adipogenesis and provide evidence to add ERK to this working model.
Related Topics
Concepts
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1101/2024.02.21.581425
- https://www.biorxiv.org/content/biorxiv/early/2024/02/21/2024.02.21.581425.full.pdf
- OA Status
- green
- References
- 56
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4392189711
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4392189711Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1101/2024.02.21.581425Digital Object Identifier
- Title
-
FSTL1 is an antagonist of ERK1/2 phosphorylation during ciliogenesis and preadipocyte differentiationWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-02-21Full publication date if available
- Authors
-
Leonardo Santos, Lucía Guggeri, Carlos Escande, José L. Badano, Victoria Prieto-EchagüeList of authors in order
- Landing page
-
https://doi.org/10.1101/2024.02.21.581425Publisher landing page
- PDF URL
-
https://www.biorxiv.org/content/biorxiv/early/2024/02/21/2024.02.21.581425.full.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.biorxiv.org/content/biorxiv/early/2024/02/21/2024.02.21.581425.full.pdfDirect OA link when available
- Concepts
-
Ciliogenesis, Adipogenesis, Cilium, Cell biology, MAPK/ERK pathway, Biology, Signal transduction, Phosphorylation, Intracellular, Chemistry, Mesenchymal stem cellTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
56Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4392189711 |
|---|---|
| doi | https://doi.org/10.1101/2024.02.21.581425 |
| ids.doi | https://doi.org/10.1101/2024.02.21.581425 |
| ids.openalex | https://openalex.org/W4392189711 |
| fwci | 0.0 |
| type | preprint |
| title | FSTL1 is an antagonist of ERK1/2 phosphorylation during ciliogenesis and preadipocyte differentiation |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11412 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9997000098228455 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1311 |
| topics[0].subfield.display_name | Genetics |
| topics[0].display_name | Genetic and Kidney Cyst Diseases |
| topics[1].id | https://openalex.org/T11928 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.998199999332428 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1311 |
| topics[1].subfield.display_name | Genetics |
| topics[1].display_name | Genetic Syndromes and Imprinting |
| topics[2].id | https://openalex.org/T13426 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9980000257492065 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | Kruppel-like factors research |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C195267511 |
| concepts[0].level | 3 |
| concepts[0].score | 0.9679359793663025 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q5119969 |
| concepts[0].display_name | Ciliogenesis |
| concepts[1].id | https://openalex.org/C122927707 |
| concepts[1].level | 3 |
| concepts[1].score | 0.7494482398033142 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q2824461 |
| concepts[1].display_name | Adipogenesis |
| concepts[2].id | https://openalex.org/C100094513 |
| concepts[2].level | 2 |
| concepts[2].score | 0.7422617673873901 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q180436 |
| concepts[2].display_name | Cilium |
| concepts[3].id | https://openalex.org/C95444343 |
| concepts[3].level | 1 |
| concepts[3].score | 0.7313368916511536 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q7141 |
| concepts[3].display_name | Cell biology |
| concepts[4].id | https://openalex.org/C57074206 |
| concepts[4].level | 3 |
| concepts[4].score | 0.7165402173995972 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q14197552 |
| concepts[4].display_name | MAPK/ERK pathway |
| concepts[5].id | https://openalex.org/C86803240 |
| concepts[5].level | 0 |
| concepts[5].score | 0.5250064134597778 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[5].display_name | Biology |
| concepts[6].id | https://openalex.org/C62478195 |
| concepts[6].level | 2 |
| concepts[6].score | 0.4578368663787842 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q828130 |
| concepts[6].display_name | Signal transduction |
| concepts[7].id | https://openalex.org/C11960822 |
| concepts[7].level | 2 |
| concepts[7].score | 0.44867774844169617 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q242736 |
| concepts[7].display_name | Phosphorylation |
| concepts[8].id | https://openalex.org/C79879829 |
| concepts[8].level | 2 |
| concepts[8].score | 0.422443687915802 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q5571762 |
| concepts[8].display_name | Intracellular |
| concepts[9].id | https://openalex.org/C185592680 |
| concepts[9].level | 0 |
| concepts[9].score | 0.33325016498565674 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[9].display_name | Chemistry |
| concepts[10].id | https://openalex.org/C198826908 |
| concepts[10].level | 2 |
| concepts[10].score | 0.06725546717643738 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q1922379 |
| concepts[10].display_name | Mesenchymal stem cell |
| keywords[0].id | https://openalex.org/keywords/ciliogenesis |
| keywords[0].score | 0.9679359793663025 |
| keywords[0].display_name | Ciliogenesis |
| keywords[1].id | https://openalex.org/keywords/adipogenesis |
| keywords[1].score | 0.7494482398033142 |
| keywords[1].display_name | Adipogenesis |
| keywords[2].id | https://openalex.org/keywords/cilium |
| keywords[2].score | 0.7422617673873901 |
| keywords[2].display_name | Cilium |
| keywords[3].id | https://openalex.org/keywords/cell-biology |
| keywords[3].score | 0.7313368916511536 |
| keywords[3].display_name | Cell biology |
| keywords[4].id | https://openalex.org/keywords/mapk/erk-pathway |
| keywords[4].score | 0.7165402173995972 |
| keywords[4].display_name | MAPK/ERK pathway |
| keywords[5].id | https://openalex.org/keywords/biology |
| keywords[5].score | 0.5250064134597778 |
| keywords[5].display_name | Biology |
| keywords[6].id | https://openalex.org/keywords/signal-transduction |
| keywords[6].score | 0.4578368663787842 |
| keywords[6].display_name | Signal transduction |
| keywords[7].id | https://openalex.org/keywords/phosphorylation |
| keywords[7].score | 0.44867774844169617 |
| keywords[7].display_name | Phosphorylation |
| keywords[8].id | https://openalex.org/keywords/intracellular |
| keywords[8].score | 0.422443687915802 |
| keywords[8].display_name | Intracellular |
| keywords[9].id | https://openalex.org/keywords/chemistry |
| keywords[9].score | 0.33325016498565674 |
| keywords[9].display_name | Chemistry |
| keywords[10].id | https://openalex.org/keywords/mesenchymal-stem-cell |
| keywords[10].score | 0.06725546717643738 |
| keywords[10].display_name | Mesenchymal stem cell |
| language | en |
| locations[0].id | doi:10.1101/2024.02.21.581425 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4306402567 |
| locations[0].source.issn | |
| locations[0].source.type | repository |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | bioRxiv (Cold Spring Harbor Laboratory) |
| locations[0].source.host_organization | https://openalex.org/I2750212522 |
| locations[0].source.host_organization_name | Cold Spring Harbor Laboratory |
| locations[0].source.host_organization_lineage | https://openalex.org/I2750212522 |
| locations[0].license | |
| locations[0].pdf_url | https://www.biorxiv.org/content/biorxiv/early/2024/02/21/2024.02.21.581425.full.pdf |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1101/2024.02.21.581425 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5022886682 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-2250-3031 |
| authorships[0].author.display_name | Leonardo Santos |
| authorships[0].countries | UY |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210156231 |
| authorships[0].affiliations[0].raw_affiliation_string | Laboratorio de Patologías del Metabolismo y el Envejecimiento, Institut Pasteur de Montevideo |
| authorships[0].institutions[0].id | https://openalex.org/I4210156231 |
| authorships[0].institutions[0].ror | https://ror.org/04dpm2z73 |
| authorships[0].institutions[0].type | facility |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210156231 |
| authorships[0].institutions[0].country_code | UY |
| authorships[0].institutions[0].display_name | Institut Pasteur de Montevideo |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Leonardo Santos |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Laboratorio de Patologías del Metabolismo y el Envejecimiento, Institut Pasteur de Montevideo |
| authorships[1].author.id | https://openalex.org/A5062124497 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Lucía Guggeri |
| authorships[1].countries | UY |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210156231 |
| authorships[1].affiliations[0].raw_affiliation_string | Laboratorio de Genética Molecular Humana, Institut Pasteur de Montevideo |
| authorships[1].institutions[0].id | https://openalex.org/I4210156231 |
| authorships[1].institutions[0].ror | https://ror.org/04dpm2z73 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210156231 |
| authorships[1].institutions[0].country_code | UY |
| authorships[1].institutions[0].display_name | Institut Pasteur de Montevideo |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Lucia Guggeri |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Laboratorio de Genética Molecular Humana, Institut Pasteur de Montevideo |
| authorships[2].author.id | https://openalex.org/A5067676527 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-9611-0903 |
| authorships[2].author.display_name | Carlos Escande |
| authorships[2].countries | UY |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210156231 |
| authorships[2].affiliations[0].raw_affiliation_string | Laboratorio de Patologías del Metabolismo y el Envejecimiento, Institut Pasteur de Montevideo |
| authorships[2].institutions[0].id | https://openalex.org/I4210156231 |
| authorships[2].institutions[0].ror | https://ror.org/04dpm2z73 |
| authorships[2].institutions[0].type | facility |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210156231 |
| authorships[2].institutions[0].country_code | UY |
| authorships[2].institutions[0].display_name | Institut Pasteur de Montevideo |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Carlos Escande |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Laboratorio de Patologías del Metabolismo y el Envejecimiento, Institut Pasteur de Montevideo |
| authorships[3].author.id | https://openalex.org/A5087188238 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-0706-8652 |
| authorships[3].author.display_name | José L. Badano |
| authorships[3].countries | UY |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210156231 |
| authorships[3].affiliations[0].raw_affiliation_string | Laboratorio de Genética Molecular Humana, Institut Pasteur de Montevideo |
| authorships[3].institutions[0].id | https://openalex.org/I4210156231 |
| authorships[3].institutions[0].ror | https://ror.org/04dpm2z73 |
| authorships[3].institutions[0].type | facility |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210156231 |
| authorships[3].institutions[0].country_code | UY |
| authorships[3].institutions[0].display_name | Institut Pasteur de Montevideo |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | José Luis Badano |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Laboratorio de Genética Molecular Humana, Institut Pasteur de Montevideo |
| authorships[4].author.id | https://openalex.org/A5080360421 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-9924-9591 |
| authorships[4].author.display_name | Victoria Prieto-Echagüe |
| authorships[4].countries | UY |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210156231 |
| authorships[4].affiliations[0].raw_affiliation_string | Laboratorio de Genética Molecular Humana, Institut Pasteur de Montevideo |
| authorships[4].institutions[0].id | https://openalex.org/I4210156231 |
| authorships[4].institutions[0].ror | https://ror.org/04dpm2z73 |
| authorships[4].institutions[0].type | facility |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210156231 |
| authorships[4].institutions[0].country_code | UY |
| authorships[4].institutions[0].display_name | Institut Pasteur de Montevideo |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Victoria Prieto-Echagüe |
| authorships[4].is_corresponding | True |
| authorships[4].raw_affiliation_strings | Laboratorio de Genética Molecular Humana, Institut Pasteur de Montevideo |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.biorxiv.org/content/biorxiv/early/2024/02/21/2024.02.21.581425.full.pdf |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | FSTL1 is an antagonist of ERK1/2 phosphorylation during ciliogenesis and preadipocyte differentiation |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11412 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9997000098228455 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1311 |
| primary_topic.subfield.display_name | Genetics |
| primary_topic.display_name | Genetic and Kidney Cyst Diseases |
| related_works | https://openalex.org/W2130801954, https://openalex.org/W1996906010, https://openalex.org/W4283783448, https://openalex.org/W2566382936, https://openalex.org/W4310573175, https://openalex.org/W4223523570, https://openalex.org/W3169439192, https://openalex.org/W4283078035, https://openalex.org/W4240770741, https://openalex.org/W2094758282 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1101/2024.02.21.581425 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4306402567 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | bioRxiv (Cold Spring Harbor Laboratory) |
| best_oa_location.source.host_organization | https://openalex.org/I2750212522 |
| best_oa_location.source.host_organization_name | Cold Spring Harbor Laboratory |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I2750212522 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://www.biorxiv.org/content/biorxiv/early/2024/02/21/2024.02.21.581425.full.pdf |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1101/2024.02.21.581425 |
| primary_location.id | doi:10.1101/2024.02.21.581425 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4306402567 |
| primary_location.source.issn | |
| primary_location.source.type | repository |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | bioRxiv (Cold Spring Harbor Laboratory) |
| primary_location.source.host_organization | https://openalex.org/I2750212522 |
| primary_location.source.host_organization_name | Cold Spring Harbor Laboratory |
| primary_location.source.host_organization_lineage | https://openalex.org/I2750212522 |
| primary_location.license | |
| primary_location.pdf_url | https://www.biorxiv.org/content/biorxiv/early/2024/02/21/2024.02.21.581425.full.pdf |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1101/2024.02.21.581425 |
| publication_date | 2024-02-21 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W2795549750, https://openalex.org/W2032918836, https://openalex.org/W2042250615, https://openalex.org/W2157671340, https://openalex.org/W2401757307, https://openalex.org/W2143161807, https://openalex.org/W4317721668, https://openalex.org/W2095731186, https://openalex.org/W2757011464, https://openalex.org/W1788396114, https://openalex.org/W2097373765, https://openalex.org/W2031640133, https://openalex.org/W2746718543, https://openalex.org/W3215731162, https://openalex.org/W2901216881, https://openalex.org/W2911913739, https://openalex.org/W2029523126, https://openalex.org/W2130651969, https://openalex.org/W1550776389, https://openalex.org/W2082951357, https://openalex.org/W2966851453, https://openalex.org/W2138499387, https://openalex.org/W2081869368, https://openalex.org/W4311630960, https://openalex.org/W2055289765, https://openalex.org/W4366280060, https://openalex.org/W4324028277, https://openalex.org/W2069899662, https://openalex.org/W4220893861, https://openalex.org/W1986960611, https://openalex.org/W2121202595, https://openalex.org/W2597573949, https://openalex.org/W2142361468, https://openalex.org/W4382241307, https://openalex.org/W2551413444, https://openalex.org/W2964802174, https://openalex.org/W2146670463, https://openalex.org/W2889425610, https://openalex.org/W2079268771, https://openalex.org/W2035653659, https://openalex.org/W2041769509, https://openalex.org/W1976709076, https://openalex.org/W2009045981, https://openalex.org/W2132812842, https://openalex.org/W2141026112, https://openalex.org/W1973345981, https://openalex.org/W2104085328, https://openalex.org/W2088989332, https://openalex.org/W2001325262, https://openalex.org/W2587423391, https://openalex.org/W1976783957, https://openalex.org/W2021301321, https://openalex.org/W3124408980, https://openalex.org/W3023182859, https://openalex.org/W2085309528, https://openalex.org/W3119901982 |
| referenced_works_count | 56 |
| abstract_inverted_index.a | 3, 69, 97, 185 |
| abstract_inverted_index.In | 209 |
| abstract_inverted_index.We | 65, 128, 152 |
| abstract_inverted_index.an | 80 |
| abstract_inverted_index.as | 133, 135 |
| abstract_inverted_index.at | 56 |
| abstract_inverted_index.be | 54 |
| abstract_inverted_index.by | 28, 107, 168 |
| abstract_inverted_index.in | 9, 12, 74, 83, 138, 144, 170, 220 |
| abstract_inverted_index.is | 2, 7, 88, 184 |
| abstract_inverted_index.of | 47, 50, 93, 96, 99, 110, 121, 141, 147, 160, 173, 187, 190, 223 |
| abstract_inverted_index.on | 32, 124, 216 |
| abstract_inverted_index.to | 30, 36, 42, 53, 90, 117, 204, 228, 231 |
| abstract_inverted_index.we | 178 |
| abstract_inverted_index.BMP | 201 |
| abstract_inverted_index.ERK | 130, 183, 230 |
| abstract_inverted_index.MAP | 181 |
| abstract_inverted_index.The | 24 |
| abstract_inverted_index.act | 31 |
| abstract_inverted_index.add | 229 |
| abstract_inverted_index.and | 14, 22, 45, 63, 76, 95, 126, 143, 157, 163, 192, 207, 225 |
| abstract_inverted_index.are | 105 |
| abstract_inverted_index.for | 72, 79 |
| abstract_inverted_index.our | 211 |
| abstract_inverted_index.the | 48, 57, 91, 108, 111, 139, 145, 148, 155, 165, 171, 214, 217, 221 |
| abstract_inverted_index.BMP4 | 169 |
| abstract_inverted_index.This | 86, 114 |
| abstract_inverted_index.also | 153 |
| abstract_inverted_index.axis | 82, 218 |
| abstract_inverted_index.data | 195, 212 |
| abstract_inverted_index.each | 43 |
| abstract_inverted_index.have | 66 |
| abstract_inverted_index.pERK | 149 |
| abstract_inverted_index.role | 71 |
| abstract_inverted_index.seem | 35 |
| abstract_inverted_index.sum, | 210 |
| abstract_inverted_index.that | 6, 180, 196, 198 |
| abstract_inverted_index.they | 104 |
| abstract_inverted_index.this | 232 |
| abstract_inverted_index.used | 27 |
| abstract_inverted_index.well | 134 |
| abstract_inverted_index.work | 115 |
| abstract_inverted_index.FSTL1 | 1, 29, 73, 122, 142, 191, 199 |
| abstract_inverted_index.Here, | 177 |
| abstract_inverted_index.added | 174 |
| abstract_inverted_index.aimed | 116 |
| abstract_inverted_index.cilia | 136, 158 |
| abstract_inverted_index.group | 98 |
| abstract_inverted_index.novel | 70 |
| abstract_inverted_index.since | 103 |
| abstract_inverted_index.Fstl1. | 176 |
| abstract_inverted_index.U0126. | 151 |
| abstract_inverted_index.action | 51, 123 |
| abstract_inverted_index.called | 101 |
| abstract_inverted_index.caused | 106 |
| abstract_inverted_index.cilia. | 113 |
| abstract_inverted_index.health | 13 |
| abstract_inverted_index.kinase | 182 |
| abstract_inverted_index.length | 137 |
| abstract_inverted_index.level, | 59 |
| abstract_inverted_index.levels | 132 |
| abstract_inverted_index.model. | 234 |
| abstract_inverted_index.remain | 52 |
| abstract_inverted_index.target | 33 |
| abstract_inverted_index.tested | 164 |
| abstract_inverted_index.tissue | 44 |
| abstract_inverted_index.absence | 140 |
| abstract_inverted_index.cancer, | 20 |
| abstract_inverted_index.obesity | 94 |
| abstract_inverted_index.pathway | 87 |
| abstract_inverted_index.primary | 112 |
| abstract_inverted_index.propose | 179 |
| abstract_inverted_index.provide | 193, 226 |
| abstract_inverted_index.several | 10, 46 |
| abstract_inverted_index.suggest | 197 |
| abstract_inverted_index.tissues | 34 |
| abstract_inverted_index.working | 233 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.activate | 37 |
| abstract_inverted_index.analyzed | 129, 154 |
| abstract_inverted_index.disease, | 15, 19 |
| abstract_inverted_index.dynamics | 159 |
| abstract_inverted_index.evidence | 78, 227 |
| abstract_inverted_index.identify | 118 |
| abstract_inverted_index.interest | 215 |
| abstract_inverted_index.involved | 8 |
| abstract_inverted_index.mediator | 186 |
| abstract_inverted_index.modulate | 205 |
| abstract_inverted_index.obesity. | 23 |
| abstract_inverted_index.pathways | 26 |
| abstract_inverted_index.presence | 146, 172 |
| abstract_inverted_index.provided | 77 |
| abstract_inverted_index.relevant | 89 |
| abstract_inverted_index.secreted | 4 |
| abstract_inverted_index.specific | 41 |
| abstract_inverted_index.unveiled | 68 |
| abstract_inverted_index.different | 38 |
| abstract_inverted_index.including | 16, 60 |
| abstract_inverted_index.inhibitor | 150 |
| abstract_inverted_index.mediators | 40, 62, 120 |
| abstract_inverted_index.molecular | 58 |
| abstract_inverted_index.processes | 11 |
| abstract_inverted_index.reinforce | 213 |
| abstract_inverted_index.signaling | 25, 167, 203 |
| abstract_inverted_index.additional | 194 |
| abstract_inverted_index.conditions | 100 |
| abstract_inverted_index.determined | 55 |
| abstract_inverted_index.downstream | 189 |
| abstract_inverted_index.mechanisms | 49 |
| abstract_inverted_index.modulation | 222 |
| abstract_inverted_index.previously | 67 |
| abstract_inverted_index.receptors. | 64 |
| abstract_inverted_index.FSTL1/cilia | 219 |
| abstract_inverted_index.Fstl1/cilia | 81 |
| abstract_inverted_index.antagonizes | 200 |
| abstract_inverted_index.dysfunction | 109 |
| abstract_inverted_index.ERK-mediated | 166 |
| abstract_inverted_index.adipogenesis | 224 |
| abstract_inverted_index.ciliogenesis | 75, 125, 188, 206 |
| abstract_inverted_index.ciliopathies | 102 |
| abstract_inverted_index.development, | 17 |
| abstract_inverted_index.glycoprotein | 5 |
| abstract_inverted_index.pathogenesis | 92 |
| abstract_inverted_index.preadipocyte | 84 |
| abstract_inverted_index.U0126-treated | 161 |
| abstract_inverted_index.adipogenesis. | 127, 208 |
| abstract_inverted_index.extracellular | 175 |
| abstract_inverted_index.inflammation, | 21 |
| abstract_inverted_index.intracellular | 39, 61, 119 |
| abstract_inverted_index.non-canonical | 202 |
| abstract_inverted_index.preadipocytes | 162 |
| abstract_inverted_index.cardiovascular | 18 |
| abstract_inverted_index.differentiation | 156 |
| abstract_inverted_index.phosphorylation | 131 |
| abstract_inverted_index.differentiation. | 85 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5080360421 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 5 |
| corresponding_institution_ids | https://openalex.org/I4210156231 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8299999833106995 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.03655396 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |